Global asthma prevalence in adults: findings from the cross-sectional world health survey - PubMed (original) (raw)

Global asthma prevalence in adults: findings from the cross-sectional world health survey

Teresa To et al. BMC Public Health. 2012.

Erratum in

Abstract

Background: Asthma is a major cause of disability, health resource utilization and poor quality of life world-wide. We set out to generate estimates of the global burden of asthma in adults, which may inform the development of strategies to address this common disease.

Methods: The World Health Survey (WHS) was developed and implemented by the World Health Organization in 2002-2003. A total of 178,215 individuals from 70 countries aged 18 to 45 years responded to questions related to asthma and related symptoms. The prevalence of asthma was based on responses to questions relating to self-reported doctor diagnosed asthma, clinical/treated asthma, and wheezing in the last 12 months.

Results: The global prevalence rates of doctor diagnosed asthma, clinical/treated asthma and wheezing in adults were 4.3%, 4.5%, and 8.6% respectively, and varied by as much as 21-fold amongst the 70 countries. Australia reported the highest rate of doctor diagnosed, clinical/treated asthma, and wheezing (21.0%, 21.5%, and 27.4%). Amongst those with clinical/treated asthma, almost 24% were current smokers, half reported wheezing, and 20% had never been treated for asthma.

Conclusions: This study provides a global estimate of the burden of asthma in adults, and suggests that asthma continues to be a major public health concern worldwide. The high prevalence of smoking remains a major barrier to combating the global burden of asthma. While the highest prevalence rates were observed in resource-rich countries, resource-poor nations were also significantly affected, posing a barrier to development as it stretches further the demands of non-communicable diseases.

PubMed Disclaimer

Figures

Figure 1

Figure 1

Worldwide prevalence of clinical asthma.

Figure 2

Figure 2

Worldwide prevalence of wheezing asthma.

Similar articles

Cited by

References

    1. To T, Wang C, Guan J, McLimont S, Gershon AS. What is the lifetime risk of physician-diagnosed asthma in Ontario, Canada? Am J RespirCrit Care Med. 2010;181:337–343. doi: 10.1164/rccm.200907-1035OC. - DOI - PubMed
    1. Braman SS. The global burden of asthma. Chest. 2006;130(1 Suppl):4S–12S. - PubMed
    1. Worldwide variations in the prevalence of asthma symptoms: the International Study of Asthma and Allergies in Childhood (ISAAC) EurRespir J. 1998;12:315–335. - PubMed
    1. Masoli M, Fabian D, Holt S, Beasley R. Global Initiative for Asthma (GINA) Program. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy. 2004;59(5):469–478. doi: 10.1111/j.1398-9995.2004.00526.x. - DOI - PubMed
    1. Variations in the prevalence of respiratory symptoms, self-reported asthma attacks, and use of asthma medication in the European Community Respiratory Health Survey (ECRHS) EurRespir J. 1996;9:687–695. - PubMed

MeSH terms

LinkOut - more resources